Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sapience Therapeutics

Request full access

A preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs

Town of Greenburgh, United StatesFounded 2015Biotech & Life Sciences

About Sapience Therapeutics

Sapience Therapeutics is a biotechnology company focused on developing peptide inhibitors to target intracellular protein-protein interactions in cancer cells. The company's discovery platform generates drug candidates that specifically address transcriptional regulation of oncogenic and immune modulatory proteins. Their lead candidate, ST101, is designed to induce cell death in solid tumors such as breast cancer, melanoma, prostate cancer, and glioblastoma, as well as in hematologic malignancies. Sapience Therapeutics operates in the oncology market, serving patients with unmet medical needs. The company generates revenue through the development and potential commercialization of its therapeutic candidates.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Town of Greenburgh, United States
Employees
25
Open positions
None listed
Dealroom signal
62.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Oncology, Neurology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing May 2023 $2M — National Cancer Institute SBIR Development Center ↗
GRANTOther financing Oct 2022 — — National Cancer Institute SBIR Development Center ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Sapience Therapeutics website traffic

Latest recorded traffic for Sapience Therapeutics is 2.9K monthly website visits, up 52.6% over the last three months. Sapience Therapeutics's team declined 21.9% over the past year.

Latest monthly visits2.9K 3-month web change+52.6% 1-year team growth-21.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Sapience Therapeutics in the Town of Greenburgh ecosystem

Live from Dealroom

The Sapience Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A8 investors entered at this stage

  • Eshelman Ventures
  • Celgene
  • Healthlink Capital
  • TaiAn Technologies
  • Connectivity Ventures Fund
  • NexPoint
  • Bristol-Myers Squibb
  • Kingdon Capital

Other known investors1 additional known investor

  • Columbia University
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sapience Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sapience Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.